{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:28:15Z","timestamp":1782865695883,"version":"3.54.5"},"reference-count":67,"publisher":"MDPI AG","issue":"3","license":[{"start":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T00:00:00Z","timestamp":1580774400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>A variety of Magnetic Resonance (MR) and nuclear medicine (NM) techniques have been used in symptomatic and presymptomatic SCA2 gene carriers to explore, in vivo, the physiopathological biomarkers of the neurological dysfunctions characterizing the associated progressive disease that presents with a cerebellar syndrome, or less frequently, with a levodopa-responsive parkinsonian syndrome. Morphometry performed on T1-weighted images and diffusion MR imaging enable structural and microstructural evaluation of the brain in presymptomatic and symptomatic SCA2 gene carriers, in whom they show the typical pattern of olivopontocerebellar atrophy observed at neuropathological examination. Proton MR spectroscopy reveals, in the pons and cerebellum of SCA2 gene carriers, a more pronounced degree of abnormal neurochemical profile compared to other spinocerebellar ataxias with decreased NAA\/Cr and Cho\/Cr, increased mi\/Cr ratios, and decreased NAA and increased mI concentrations. These neurochemical abnormalities are detectable also in presymtomatic gene carriers. Resting state functional MRI (rsfMRI) demonstrates decreased functional connectivity within the cerebellum and of the cerebellum with fronto-parietal cortices and basal ganglia in symptomatic SCA2 subjects. 18F-fluorodeoxyglucose Positron Emission Tomography (PET) shows a symmetric decrease of the glucose uptake in the cerebellar cortex, the dentate nucleus, the brainstem and the parahippocampal cortex. Single photon emission tomography and PET using several radiotracers have revealed almost symmetric nigrostriatal dopaminergic dysfunction irrespective of clinical signs of parkinsonism which are already present in presymtomatic gene carriers. Longitudinal small size studies have proven that morphometry and diffusion MR imaging can track neurodegeneration in SCA2, and hence serve as progression biomarkers. So far, such a capability has not been reported for proton MR spectroscopy, rsfMRI and NM techniques. A search for the best surrogate marker for future clinical trials represents the current challenge for the neuroimaging community.<\/jats:p>","DOI":"10.3390\/ijms21031020","type":"journal-article","created":{"date-parts":[[2020,2,5]],"date-time":"2020-02-05T03:18:48Z","timestamp":1580872728000},"page":"1020","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":19,"title":["Neuroimaging Biomarkers in SCA2 Gene Carriers"],"prefix":"10.3390","volume":"21","author":[{"given":"Mario","family":"Mascalchi","sequence":"first","affiliation":[{"name":"Department of Clinical and Experimental Biomedical Sciences, University of Florence, 50121 Florence, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Vella","sequence":"additional","affiliation":[{"name":"Nuclear Medicine at University Hospital, 53100 Siena, Italy"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2020,2,4]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/B978-0-444-63233-3.00011-7","article-title":"The CAG-polyglutamine repeat diseases: A clinical, molecular, genetic, and pathophysiologic nosology","volume":"147","author":"Stoyas","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12311-008-0019-y","article-title":"Spinocerebellar Ataxia 2 (SCA2)","volume":"7","author":"Rub","year":"2008","journal-title":"Cerebellum"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1111\/j.1440-1789.2010.01176.x","article-title":"An autopsy case of an aged patient with spinocerebellar ataxia type 2","volume":"31","author":"Ishida","year":"2011","journal-title":"Neuropathology"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.pneurobio.2013.01.001","article-title":"Clinical features, neurogenetics and neuropathology of the polyglutamine spinocerebellar ataxias type 1, 2, 3, 6 and 7","volume":"104","author":"Rub","year":"2013","journal-title":"Progr. Neurobiol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/B978-0-444-63956-1.00008-4","article-title":"The neuropathology of the adult cerebellum","volume":"154","author":"Koeppen","year":"2018","journal-title":"Hand. Clin. Neurol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12311-014-0610-3","article-title":"Consensus Paper: Radiological biomarkers of cerebellar diseases","volume":"14","author":"Currie","year":"2015","journal-title":"Cerebellum"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/bs.irn.2018.09.011","article-title":"Neuroimaging applications in chronic ataxias","volume":"143","author":"Mascalchi","year":"2018","journal-title":"Int. Rev. Neurobiol."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/brain\/119.5.1497","article-title":"Autosomal dominant cerebellar ataxia type I. Clinical features and MRI in families with SCA1, SCA2 andSCA3","volume":"119","author":"Burk","year":"1996","journal-title":"Brain"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.3174\/ajnr.A0716","article-title":"Diffusion tensor imaging of spinocerebellar ataxias types 1 and 2","volume":"28","author":"Mandelli","year":"2007","journal-title":"AJNR Am. J. Neuroradiol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1111\/j.1468-1331.2008.02524.x","article-title":"The \u2018hot cross bun\u2019 sign in the patients with spinocerebellar ataxia","volume":"16","author":"Lee","year":"2009","journal-title":"Eur. J. Neurol."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/B978-0-444-51892-7.00004-8","article-title":"Magnetic resonance and nuclear medicine imaging in ataxias","volume":"103","author":"Mascalchi","year":"2012","journal-title":"Handb. Clin. Neurol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1093\/brain\/121.9.1687","article-title":"Autosomal Dominant Ataxia Type I. MRI-based volumetry of the posterior fossa structures and basal ganglia in spinocerebellar ataxias type 1, 2 and 3","volume":"121","author":"Klockgether","year":"1998","journal-title":"Brain"},{"key":"ref_13","doi-asserted-by":"crossref","unstructured":"Mascalchi, M., Diciotti, S., Giannelli, M., Ginestroni, A., Soricelli, A., Nicolai, E., Aiello, M., Tessa, C., Galli, L., and Dotti, M.T. (2014). Progression of brain atrophy in SCA2. A longitudinal TBM study. PLoS ONE, 9.","DOI":"10.1371\/journal.pone.0089410"},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Han, Q., Yang, J., Xiong, H., and Shang, H. (2018). Voxel-based meta-analysis of gray and white matter volume abnormalities in spinocerebellar ataxia type 2. Brain Behav., 8.","DOI":"10.1002\/brb3.1099"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S1474-4422(13)70104-2","article-title":"Biological and clinical characteristics of individuals at risk for spinocerebellar ataxia types 1, 2, 3, and 6 in the longitudinal RISCA study: Analysis of baseline data","volume":"12","author":"Jacobi","year":"2013","journal-title":"Lancet Neurol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/acn3.504","article-title":"Brain atrophy measures in preclinical and manifest spinocerebellar ataxia type 2","volume":"5","author":"Reetz","year":"2018","journal-title":"Ann. Clin. Transl. Neurol."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.neuroimage.2008.06.036","article-title":"Brain white matter damage in SCA1 and SCA2. An in vivo study using voxel-based morphometry, histogram analysis of mean diffusivity and tract-based spatial statistics","volume":"43","author":"Ginestroni","year":"2008","journal-title":"NeuroImage"},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/jon.12534","article-title":"Structural complexity of the cerebellum and cerebral cortex is reduced in spinocerebellar ataxia type 2","volume":"28","author":"Marzi","year":"2018","journal-title":"J. Neuroimaging"},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1093\/brain\/awh201","article-title":"Brainstem neurodegeneration correlates with clinical dysfunction in SCA1 but not in SCA2. A volumetric, diffusion and quantitative proton spectroscopy MR study","volume":"127","author":"Guerrini","year":"2004","journal-title":"Brain"},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/mds.25757","article-title":"Supratentorial and infratentorial damage in spinocerebellar ataxia 2: A diffusion-weighted MRI study","volume":"29","author":"Salvatore","year":"2014","journal-title":"Mov. Disord."},{"key":"ref_21","doi-asserted-by":"crossref","unstructured":"Hernandez-Castillo, C.R., Galvez, V., Mercadillo, R., Diaz, R., Campos-Romo, A., and Fernandez-Ruiz, J. (2015). Extensive white matter alterations and its correlations with ataxia severity in SCA 2 patients. PLoS ONE, 10.","DOI":"10.1371\/journal.pone.0135449"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.neuroscience.2017.10.007","article-title":"Microstructural MRI basis of the cognitive functions in patients with spinocerebellar ataxia type 2","volume":"366","author":"Olivito","year":"2017","journal-title":"Neuroscience"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.nicl.2018.06.011","article-title":"Autosomal dominant cerebellar ataxias: Imaging biomarkers with high effect sizes","volume":"19","author":"Adanyeguh","year":"2018","journal-title":"NeuroImage Clin."},{"key":"ref_24","doi-asserted-by":"crossref","unstructured":"Mascalchi, M., Marzi, C., Giannelli, M., Ciulli, S., Bianchi, A., Ginestroni, A., Tessa, C., Nicolai, E., Aiello, M., and Salvatore, E. (2018). Histogram analysis of DTI-derived indices reveals pontocerebellar degeneration and its progression in SCA2. PLoS ONE, 13.","DOI":"10.1371\/journal.pone.0200258"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.2214\/ajr.164.6.7754871","article-title":"Perspective clinical MR Spectroscopy: Fundamentals, current applications, and future potential","volume":"164","author":"Cousins","year":"1995","journal-title":"AJR Am. J. Roentgenol."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"\u00d6z, G. (2016). Magnetic Resonance Spectroscopy of Degenerative Brain Diseases, Springer. [1st ed.].","DOI":"10.1007\/978-3-319-33555-1"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/nbm.1940020505","article-title":"Brain metabolites as1H NMR markers of neuronal and glial disorders","volume":"2","author":"Gill","year":"1989","journal-title":"NMR Biomed."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1002\/nbm.1940040203","article-title":"A review of chemical issues in 1H NMR spectroscopy: N-acetyl-l-aspartate, creatine and choline","volume":"4","author":"Miller","year":"1991","journal-title":"NMR Biomed."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1016\/0301-0082(95)00014-M","article-title":"N-Acetylaspartate in neuropsychiatric disorders","volume":"46","author":"Tsai","year":"1995","journal-title":"Prog. Neurobiol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1159\/000111347","article-title":"Multinuclear NMR studies on the energy metabolism of glial and neuronal cells","volume":"15","author":"Brand","year":"1993","journal-title":"Dev. Neurosci."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.neuroimage.2011.12.038","article-title":"The neurochemical profile quantified by in vivo 1HNMR spectroscopy","volume":"61","author":"Duarte","year":"2012","journal-title":"Neuroimage"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1002\/jmri.10189","article-title":"Single voxel long TE MR spectroscopy of the normal brainstem and cerebellum","volume":"16","author":"Mascalchi","year":"2002","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/jmri.1078","article-title":"Proton magnetic resonance spectroscopic imaging reveals differences in spinocerebellar ataxia types 2 and 6","volume":"13","author":"Boesch","year":"2001","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.brainres.2005.05.015","article-title":"1H magnetic resonance spectroscopy of autosomal ataxias","volume":"1049","author":"Viau","year":"2005","journal-title":"Brain Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/jmri.20846","article-title":"Differentiation of SCA2 from MSA-C using proton magnetic resonance spectroscopic imaging","volume":"25","author":"Boesch","year":"2007","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/jmri.21804","article-title":"Impact of CSF contamination on brain metabolites evaluation with 1H-MR spectroscopy. A single voxel study of the cerebellar vermis in patients with degenerative ataxias","volume":"30","author":"Guerrini","year":"2009","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1007\/s12311-010-0213-6","article-title":"Distinct neurochemical profiles of spinocerebellar ataxias 1, 2, 6, and cerebellar multiple system atrophy","volume":"10","author":"Oz","year":"2011","journal-title":"Cerebellum"},{"key":"ref_38","doi-asserted-by":"crossref","unstructured":"Lirng, J.F., Wang, P.S., Chen, H.C., Soong, B.W., Guo, W.Y., Wu, H.M., and Chang, C.Y. (2012). Differences between spinocerebellar ataxias and multiple system atrophy-cerebellar type on proton magnetic resonance spectroscopy. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047925"},{"key":"ref_39","doi-asserted-by":"crossref","unstructured":"Wang, P.S., Chen, H.C., Wu, H.M., Lirng, J.F., Wu, Y.T., and Soong, B.W. (2012). Association between Proton Magnetic Resonance Spectroscopy measurements and CAG repeat number in patients with Spinocerebellar Ataxias 2, 3, or 6. PLoS ONE, 7.","DOI":"10.1371\/journal.pone.0047479"},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s40673-014-0017-4","article-title":"The merit of proton magnetic resonance spectroscopy in the longitudinal assessment of spinocerebellar ataxias and multiple system atrophy-cerebellar type","volume":"1","author":"Chen","year":"2014","journal-title":"Cerebellum Ataxias"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1002\/mds.26181","article-title":"In vivo neurometabolic profiling in patients with spinocerebellar ataxia types 1, 2, 3, and 7","volume":"30","author":"Adanyeguh","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/ana.25212","article-title":"Neurochemical abnormalities in premanifest and early spinocerebellar ataxias","volume":"83","author":"Joers","year":"2018","journal-title":"Ann. Neurol."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.neubiorev.2019.12.019","article-title":"Neurochemical profiles in hereditary ataxias: A meta-analysis of Magnetic Resonance Spectroscopy studies","volume":"108","author":"Krahe","year":"2019","journal-title":"Neurosci. Biobehav. Rev."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1016\/j.nicl.2018.03.013","article-title":"Resting-state connectivity in neurodegenerative disorders: Is there potential for an imaging biomarker?","volume":"18","author":"Hohenfeld","year":"2018","journal-title":"NeuroImage Clin."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1002\/jmri.20580","article-title":"Design and analysis of fMRI studies with neurologically impaired patients","volume":"23","author":"Price","year":"2006","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.parkreldis.2012.08.011","article-title":"Preclinical and clinical neural network changes in SCA2 parkinsonism","volume":"19","author":"Wu","year":"2013","journal-title":"Parkinsonism Relat. Disord."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1002\/mds.26284","article-title":"Modifications of resting state networks in spinocerebellar ataxia type 2","volume":"30","author":"Cocozza","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/mds.26320","article-title":"Functional connectivity changes related to cognitive and motor performance in spinocerebellar ataxia type 2","volume":"30","author":"Galvez","year":"2015","journal-title":"Mov. Disord."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.nicl.2017.03.009","article-title":"Neural substrates of motor and cognitive dysfunctions in SCA2 patients: A network-based statistics analysis","volume":"14","author":"Olivito","year":"2017","journal-title":"NeuroImage Clin."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/jmri.22825","article-title":"Movement disorders: Role of imaging in diagnosis","volume":"35","author":"Mascalchi","year":"2012","journal-title":"J. Magn. Reson. Imaging"},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/B978-0-444-63956-1.00015-1","article-title":"Nuclear medicine of the cerebellum","volume":"154","author":"Vella","year":"2018","journal-title":"Handb. Clin. Neurol."},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1001\/archneur.62.8.1280","article-title":"Dopamine Transporter Positron Emission Tomography in Spinocerebellar Ataxias Type 1, 2, 3, and 6","volume":"62","author":"Reimold","year":"2005","journal-title":"Arch. Neurol."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1007\/s00415-006-0383-9","article-title":"Regional patterns of cerebral glucose metabolism in spinocerebellar ataxia type 2, 3 and 6: A voxel-based FDG-positron emission tomography analysis","volume":"254","author":"Wang","year":"2007","journal-title":"J. Neurol."},{"key":"ref_54","doi-asserted-by":"crossref","unstructured":"Oh, M., Kim, J.S., Oh, J.S., Lee, C.S., and Chung, S.J. (2017). Different subregional metabolism patterns in patients with cerebellar ataxia by 18F-fluorodeoxyglucose positron emission tomography. PLoS ONE, 12.","DOI":"10.1371\/journal.pone.0173275"},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1468-1331.2005.01011.x","article-title":"Positron emission tomography and magnetic resonance imaging in spinocerebellar ataxia type 2: A study of symptomatic and asymptomatic individuals","volume":"12","author":"Inagaki","year":"2005","journal-title":"Eur. J. Neurol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1002\/mds.10243","article-title":"Dopa-responsive parkinsonism phenotype of spinocerebellar ataxia type 2","volume":"17","author":"Lu","year":"2002","journal-title":"Mov. Disord."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1002\/mds.20159","article-title":"Abnormalities of dopaminergic neurotransmission in SCA2: A combined 123I-betaCIT and 123I-IBZM SPECT study","volume":"19","author":"Boesch","year":"2004","journal-title":"Mov. Disord."},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1002\/ana.20054","article-title":"Reduced striatal [123 I]FP-CIT binding in SCA2 patients without parkinsonism","volume":"55","author":"Varrone","year":"2004","journal-title":"Ann. Neurol."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1001\/archneur.64.10.1510","article-title":"Importance of low-range CAG expansion and CAA interruption in SCA2 Parkinsonism","volume":"64","author":"Kim","year":"2007","journal-title":"Arch. Neurol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1002\/ana.10055","article-title":"Spinocerebellar ataxia type 2 presenting as familial levodopa-responsive parkinsonism","volume":"50","author":"Shan","year":"2001","journal-title":"Ann. Neurol."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1212\/01.WNL.0000035625.19871.DC","article-title":"SCA-2 presenting as parkinsonism in an Alberta family: Clinical, genetic, and PET findings","volume":"59","author":"Furtado","year":"2002","journal-title":"Neurology"},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"3316","DOI":"10.1093\/brain\/awv255","article-title":"No parkinsonism in SCA2 and SCA3 despite severe neurodegeneration of the dopaminergic substantia nigra","volume":"138","author":"Reimold","year":"2015","journal-title":"Brain"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1007\/s00259-006-0104-8","article-title":"Topography of cerebral monoamine transporter availability in families with SCA2 mutations: A voxel-wise [123I]beta-CIT SPECT analysis","volume":"33","author":"Scherfler","year":"2006","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1038\/s41582-018-0051-6","article-title":"Spinocerebellar ataxias: Prospects and challenges for therapy development","volume":"14","author":"Ashizawa","year":"2018","journal-title":"Nat. Rev. Neurol."},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1002\/mds.10192","article-title":"Chronic thalamic stimulation in a patient with spinocerebellar ataxia type 2","volume":"18","author":"Pirker","year":"2003","journal-title":"Mov. Disord."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3389\/fpsyt.2014.00033","article-title":"Restoring cognitive functions using non-invasive brain stimulation techniques in patients with cerebellar disorders","volume":"5","author":"Pope","year":"2014","journal-title":"Front. Psychiatry"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1001\/archneur.59.6.1044","article-title":"The use of quantitative methods in clinical trials for spinocerebellar ataxia","volume":"59","author":"Schulte","year":"2002","journal-title":"Arch. Neurol."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/1020\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T08:54:30Z","timestamp":1760172870000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/21\/3\/1020"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,2,4]]},"references-count":67,"journal-issue":{"issue":"3","published-online":{"date-parts":[[2020,2]]}},"alternative-id":["ijms21031020"],"URL":"https:\/\/doi.org\/10.3390\/ijms21031020","relation":{},"ISSN":["1422-0067"],"issn-type":[{"value":"1422-0067","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,2,4]]}}}